Exopharm
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
+61 391110026Website
www.exopharm.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Exopharm
Exopharm Limited (ASX:EX1) is a clinical-stage biopharmaceutical company at the forefront of transformative medicines using exosomes, or extracellular vesicles (EVs), and is pursuing a pipeline-driven platform strategy. Exosomes can be loaded with a variety of active pharmaceutical ingredients (APIs) and can be targeted to selected cell and tissue types (tropism) - improving the safety profile of the APIs and providing better treatments. Exosome delivery of DNA and other gene therapies into the nucleus of the patient's cells can improve treatment of inherited medical conditions. Exosomes are an alternative means of drug delivery inside the body, alongside technologies such as lipid nanoparticles (LNP), cell-penetrating peptides, viral vectors and liposomes. The drug delivery industry is growing at a compound annual growth rate (CAGR) of 5% and is currently valued at about US$175 billion ($233 billion)[1].Explore more
Exopharm Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Exopharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Exopharm launches new products
Funding: Get notified immidiatlly once Exopharm has new funding data
Exopharm, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Exopharm has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Exopharm had a recent Job posting/layoffs
Check out if Exopharm is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Exopharm recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Exopharm
Recommended Actions
Find VP level buyers at Exopharm
Find 2 more new buyers
Compare Similar Companies to Exopharm
Compare insights from companies similar to Exopharm, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Exopharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Exopharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Exopharm.
Exopharm Tech Stack
A closer look at the technologies used by Exopharm
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Exopharm
Sign Up For FreeTo access detailed company insights
Exopharm Limited (ASX:EX1) is a clinical-stage biopharmaceutical company at the forefront of transformative medicines using exosomes, or extracellular vesicles (EVs), and is pursuing a pipeline-driven platform strategy. Exosomes can be loaded with a variety of active pharmaceutical ingredients (APIs) and can be targeted to selected cell and tissue... Read More
